Bi-allelic variation of FANCJ (BRIP1) identified in premature ovarian insufficiency

Objective Premature ovarian insufficiency (POI) is defined as the depletion of ovarian function before 40 years of age, affecting approximately 3.7% of women in their reproductive age worldwide. Previous studies revealed several genes involved in the Fanconi anaemia (FA) pathway participate in the p...

Full description

Saved in:
Bibliographic Details
Main Authors: Chunmei Zhang, Ting Guo, Xin Liang, Yingying Qin, Anmiao Sun, Xinmiao He, Mengchun Hu, Hongyuan Liu, Xiaowei Wu, Manting Yang, Runxin Yao, Shidou Zhao, Xue Jiao
Format: Article
Language:English
Published: BMJ Publishing Group 2025-05-01
Series:Gynecology and Obstetrics Clinical Medicine
Online Access:https://gocm.bmj.com/content/5/2/e000208.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849762128869720064
author Chunmei Zhang
Ting Guo
Xin Liang
Yingying Qin
Anmiao Sun
Xinmiao He
Mengchun Hu
Hongyuan Liu
Xiaowei Wu
Manting Yang
Runxin Yao
Shidou Zhao
Xue Jiao
author_facet Chunmei Zhang
Ting Guo
Xin Liang
Yingying Qin
Anmiao Sun
Xinmiao He
Mengchun Hu
Hongyuan Liu
Xiaowei Wu
Manting Yang
Runxin Yao
Shidou Zhao
Xue Jiao
author_sort Chunmei Zhang
collection DOAJ
description Objective Premature ovarian insufficiency (POI) is defined as the depletion of ovarian function before 40 years of age, affecting approximately 3.7% of women in their reproductive age worldwide. Previous studies revealed several genes involved in the Fanconi anaemia (FA) pathway participate in the pathogenesis of POI, such as FANCA and FANCM. FA pathway maintains rapid proliferation in the developing primordial germ cells by deregulating transcription-replication conflicts, which is crucial for the establishment of sufficient ovarian reserve. FANCJ encodes a DNA helicase located downstream of the FA pathway promoting DNA damage repair and cell proliferation. Recently, two heterozygous FANCJ missense variants have been reported in patients with POI, suggesting haploinsufficiency of FANCJ participates in the pathogenesis of the disease. In this study, to further explore the contribution of FANCJ variants in POI, we reported a rare homozygous FANCJ start-loss variation in one patient with POI and illustrated its pathogenicity by in vitro functional studies.Methods The loss-of-function (LoF) variants of FANCJ were screened in our internal whole-exome sequencing (WES) database of POI. Sanger sequencing and WES analysis were employed on the proband and the patient’s family members to illustrate the origin of the bi-allelic variant. Cycloheximide chase assay was performed to demonstrate the impact of the variant on the protein stability of FANCJ. Protein ubiquitination assay was performed to confirm the accelerated degradation pathway of FANCJ protein.Results Through the variation screening, a bi-allelic variant of FANCJ (NM_032043.3:c.1A>G, p.Met1Val) was identified in one case. The functional study showed that the start-loss variant affected FANCJ protein stability by accelerated protein degradation through the ubiquitin-proteasome pathway.Conclusion Our findings provide further genetic evidence of the FANCJ variant participating in the pathogenesis of POI, expand the inherited mode and highlight the essential role of the FA pathway in maintaining ovarian function.
format Article
id doaj-art-c9f65b1ae40b4ad0b1a623495a077f4e
institution DOAJ
issn 2097-0587
2667-1646
language English
publishDate 2025-05-01
publisher BMJ Publishing Group
record_format Article
series Gynecology and Obstetrics Clinical Medicine
spelling doaj-art-c9f65b1ae40b4ad0b1a623495a077f4e2025-08-20T03:05:49ZengBMJ Publishing GroupGynecology and Obstetrics Clinical Medicine2097-05872667-16462025-05-015210.1136/gocm-2025-000208Bi-allelic variation of FANCJ (BRIP1) identified in premature ovarian insufficiencyChunmei Zhang0Ting Guo1Xin Liang2Yingying Qin3Anmiao Sun4Xinmiao He5Mengchun Hu6Hongyuan Liu7Xiaowei Wu8Manting Yang9Runxin Yao10Shidou Zhao11Xue Jiao124 Dongfang Municipal Health Commission, Dongfang, Hainan, ChinaDepartment of Gastrointestinal Translational Research, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital, Beijing, ChinaShandong University National Research Center for Assisted Reproductive Technology and Reproductive Genetics, Jinan, Shandong, ChinaprofessorShandong Provincial Clinical Research Center for Reproductive Health, Shandong Key Laboratory of Reproductive Research and Birth Defect Prevention, Jinan, Shandong, ChinaShandong University State Key Laboratory of Reproductive Medicine and Offspring Health, Center for Reproductive Medicine, Institute of Women, Children and Reproductive Health, Jinan, Shandong, ChinaShandong University State Key Laboratory of Reproductive Medicine and Offspring Health, Center for Reproductive Medicine, Institute of Women, Children and Reproductive Health, Jinan, Shandong, ChinaShandong University State Key Laboratory of Reproductive Medicine and Offspring Health, Center for Reproductive Medicine, Institute of Women, Children and Reproductive Health, Jinan, Shandong, ChinaShandong Provincial Clinical Research Center for Reproductive Health, Shandong Key Laboratory of Reproductive Research and Birth Defect Prevention, Jinan, Shandong, ChinaShandong University State Key Laboratory of Reproductive Medicine and Offspring Health, Center for Reproductive Medicine, Institute of Women, Children and Reproductive Health, Jinan, Shandong, ChinaShandong Provincial Clinical Research Center for Reproductive Health, Shandong Key Laboratory of Reproductive Research and Birth Defect Prevention, Jinan, Shandong, ChinaShandong University State Key Laboratory of Reproductive Medicine and Offspring Health, Center for Reproductive Medicine, Institute of Women, Children and Reproductive Health, Jinan, Shandong, ChinaShandong University State Key Laboratory of Reproductive Medicine and Offspring Health, Center for Reproductive Medicine, Institute of Women, Children and Reproductive Health, Jinan, Shandong, ChinaObjective Premature ovarian insufficiency (POI) is defined as the depletion of ovarian function before 40 years of age, affecting approximately 3.7% of women in their reproductive age worldwide. Previous studies revealed several genes involved in the Fanconi anaemia (FA) pathway participate in the pathogenesis of POI, such as FANCA and FANCM. FA pathway maintains rapid proliferation in the developing primordial germ cells by deregulating transcription-replication conflicts, which is crucial for the establishment of sufficient ovarian reserve. FANCJ encodes a DNA helicase located downstream of the FA pathway promoting DNA damage repair and cell proliferation. Recently, two heterozygous FANCJ missense variants have been reported in patients with POI, suggesting haploinsufficiency of FANCJ participates in the pathogenesis of the disease. In this study, to further explore the contribution of FANCJ variants in POI, we reported a rare homozygous FANCJ start-loss variation in one patient with POI and illustrated its pathogenicity by in vitro functional studies.Methods The loss-of-function (LoF) variants of FANCJ were screened in our internal whole-exome sequencing (WES) database of POI. Sanger sequencing and WES analysis were employed on the proband and the patient’s family members to illustrate the origin of the bi-allelic variant. Cycloheximide chase assay was performed to demonstrate the impact of the variant on the protein stability of FANCJ. Protein ubiquitination assay was performed to confirm the accelerated degradation pathway of FANCJ protein.Results Through the variation screening, a bi-allelic variant of FANCJ (NM_032043.3:c.1A>G, p.Met1Val) was identified in one case. The functional study showed that the start-loss variant affected FANCJ protein stability by accelerated protein degradation through the ubiquitin-proteasome pathway.Conclusion Our findings provide further genetic evidence of the FANCJ variant participating in the pathogenesis of POI, expand the inherited mode and highlight the essential role of the FA pathway in maintaining ovarian function.https://gocm.bmj.com/content/5/2/e000208.full
spellingShingle Chunmei Zhang
Ting Guo
Xin Liang
Yingying Qin
Anmiao Sun
Xinmiao He
Mengchun Hu
Hongyuan Liu
Xiaowei Wu
Manting Yang
Runxin Yao
Shidou Zhao
Xue Jiao
Bi-allelic variation of FANCJ (BRIP1) identified in premature ovarian insufficiency
Gynecology and Obstetrics Clinical Medicine
title Bi-allelic variation of FANCJ (BRIP1) identified in premature ovarian insufficiency
title_full Bi-allelic variation of FANCJ (BRIP1) identified in premature ovarian insufficiency
title_fullStr Bi-allelic variation of FANCJ (BRIP1) identified in premature ovarian insufficiency
title_full_unstemmed Bi-allelic variation of FANCJ (BRIP1) identified in premature ovarian insufficiency
title_short Bi-allelic variation of FANCJ (BRIP1) identified in premature ovarian insufficiency
title_sort bi allelic variation of fancj brip1 identified in premature ovarian insufficiency
url https://gocm.bmj.com/content/5/2/e000208.full
work_keys_str_mv AT chunmeizhang biallelicvariationoffancjbrip1identifiedinprematureovarianinsufficiency
AT tingguo biallelicvariationoffancjbrip1identifiedinprematureovarianinsufficiency
AT xinliang biallelicvariationoffancjbrip1identifiedinprematureovarianinsufficiency
AT yingyingqin biallelicvariationoffancjbrip1identifiedinprematureovarianinsufficiency
AT anmiaosun biallelicvariationoffancjbrip1identifiedinprematureovarianinsufficiency
AT xinmiaohe biallelicvariationoffancjbrip1identifiedinprematureovarianinsufficiency
AT mengchunhu biallelicvariationoffancjbrip1identifiedinprematureovarianinsufficiency
AT hongyuanliu biallelicvariationoffancjbrip1identifiedinprematureovarianinsufficiency
AT xiaoweiwu biallelicvariationoffancjbrip1identifiedinprematureovarianinsufficiency
AT mantingyang biallelicvariationoffancjbrip1identifiedinprematureovarianinsufficiency
AT runxinyao biallelicvariationoffancjbrip1identifiedinprematureovarianinsufficiency
AT shidouzhao biallelicvariationoffancjbrip1identifiedinprematureovarianinsufficiency
AT xuejiao biallelicvariationoffancjbrip1identifiedinprematureovarianinsufficiency